Mylan NV
MYL
Delayed Nasdaq - 01/18 10:00:00 pm
46.51USD
-0.58%
Upcoming events
02/28/18
FY 2017 Earnings Release (Projected)
05/03/18
Q1 2018 Earnings Release (Projected)
08/09/18
Interim 2018 Earnings Release (Projected)
11/01/18
Q3 2018 Earnings Release (Projected)
Past Events
01/10/18 | 12:30amJ.P. Morgan Health Care Conference - Q&A
01/10/18J.P. Morgan Health Care Conference
11/30/17 | 09:30pmEvercore ISI Inaugural Biopharma Catalyst/Deep Dive Conference
11/06/17 | 01:00pmQ3 2017 Earnings Release
Annual results
Annual results20162017 (e)
Sales
Million $
Released
Forecast
Spread
11 077
10 994
0,75%

11 988
Operating income (EBITDA)
Million $
Released
Forecast
Spread
3 678
3 523
4,4%

3 924
Operating profit (EBIT)
Million $
Released
Forecast
Spread
3 331
3 189
4,4%

3 405
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread




Net income
Million $
Released
Forecast
Spread
480
1 054
-54%

846
EPS
 $
Released
Forecast
Spread
0,92
1,37
-33%

1,89
Announcement Date03/01/2017
Quarterly / Semiannualy publications
Quarterly resultsQ3
2017
Q4
2017 (e)
Sales
Million $
Released
Forecast
Spread
2 987
3 092
-3,4%

3 317
Operating income (EBITDA)
Million $
Released
Forecast
Spread
924
984
-6,1%

1 137
Operating profit (EBIT)
Million $
Released
Forecast
Spread
822
896
-8,3%

1 022
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread




Net income
Million $
Released
Forecast
Spread
88,3
418
-79%

480
EPS
 $
Released
Forecast
Spread
0,16
0,73
-78%

1,01
Announcement Date11/06/2017
Net sales - Rate of surprise
Operating profit - Rate of surprise
EPS - Rate of surprise